January 19th, 2019
•This protocol describes how to assess synergism between an anticancer antibody and antineoplastic drugs in preclinical models by using the combination index equation of Chou and Talalay.
Tags
Related Videos
Fluorescent Orthotopic Mouse Model of Pancreatic Cancer
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Detection of Protease Activity by Fluorescent Peptide Zymography
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Detection of Retrotransposition Activity of Hot LINE-1s by Long-Distance Inverse PCR
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved